Ryan White HIV/AIDS Program Parts A and B Integrated HIV Planning Implementation Cooperative Agreement to John Snow, Inc. (JSI), U69HA30144, 28431 [2018-13121]

Download as PDF Federal Register / Vol. 83, No. 118 / Tuesday, June 19, 2018 / Notices 28431 TABLE 1—LIST OF INFORMATION COLLECTIONS APPROVED BY OMB OMB control No. Title of collection Infant Formula Requirements .................................................................................................................................. Premarket Notification for a New Dietary Ingredient ............................................................................................... Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring .............................................. Guidance for Industry: Formal Dispute Resolution; Scientific and Technical Issues Related to Pharmaceutical Current Good Manufacturing Practice ................................................................................................................. Requests for Inspection by an Accredited Person Under the Inspection for Accredited Persons Program .......... Substances Prohibited from Use in Animal Food or Feed ..................................................................................... Class II Special Controls Guidance Document: Labeling for Natural Rubber Latex Condoms Classified Under 21 CFR 884.5300 ................................................................................................................................................. Guidance for Industry: Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During an Influenza Pandemic ............................................................................................................................. Guidance on Consultation Procedures: Foods Derived From New Plant Varieties ............................................... Human Subject Protection; Acceptance of Data From Clinical Investigations for Medical Devices ...................... Food Labeling; Calorie Labeling of Articles of Food in Vending Machines and Nutrition Labeling of Standard Menu Items in Restaurants and Similar Retail Food Establishments ................................................................. Guidance for Industry, Researchers, Patient Groups, and Food and Drug Administration Staff on Meetings with the Office of Orphan Products Development ....................................................................................................... Food Allergen Labeling and Reporting .................................................................................................................... Transfer of a Premarket Notification Clearance ...................................................................................................... Dated: June 13, 2018. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2018–13098 Filed 6–18–18; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Ryan White HIV/AIDS Program Parts A and B Integrated HIV Planning Implementation Cooperative Agreement to John Snow, Inc. (JSI), U69HA30144 Health Resources and Services Administration (HRSA), Department of Health and Human Services. ACTION: Notice of non-competitive FY 2018 supplemental award. AGENCY: This noncompetitive supplement award to JSI will support and strengthen current Ryan White HIV/ AIDS Program (RWHAP) Part A and Part B priority setting and resource allocation processes to ensure people living with HIV are linked to care, remain engaged in care, and achieve viral suppression. FOR FURTHER INFORMATION CONTACT: Dr. Rene Sterling, Acting Director, Division of State HIV/AIDS Programs, HIV/AIDS Bureau, HRSA; 5600 Fishers Lane, Room 09W50, Rockville, MD 20857; Phone: (301) 443–9017, Email: rsterling@hrsa.gov. SUPPLEMENTARY INFORMATION: Intended Recipient of the Award: JSI (U69HA30144). daltland on DSKBBV9HB2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:55 Jun 18, 2018 Jkt 244001 Amount of Non-Competitive Award: $300,000 in FY 2018. Period of Funding: July 1, 2018, through June 30, 2019. CFDA Number: No. 93.145. Authority: Sections 2606 and 2654(b) of the Public Health Service Act, as amended by the Ryan White HIV/AIDS Treatment Extension Act of 2009 (Pub. L. 111–87). Justification: In 2016, JSI was awarded a 3-year cooperative agreement under HRSA–16–082 RWHAP Integrated HIV Planning Implementation (CFDA 93.145), authorized by Sections 2606 and 2654(b) of the Public Health Service Act, as amended by the Ryan White HIV/AIDS Treatment Extension Act of 2009 (Pub. L. 111–87). The cooperative agreement was established to provide technical assistance to RWHAP Parts A and B recipients and their planning bodies regarding: (1) The integration of HIV planning across prevention, care, and treatment service delivery systems; and (2) the development, implementation, monitoring, and evaluation of Integrated HIV Prevention and Care Plans. RWHAP Parts A and B recipients and planning bodies use Integrated Plans to better inform and coordinate HIV prevention and care program planning, resource allocation, and continuous quality improvement efforts to meet the HIV service delivery needs within their jurisdictions. The proposed supplemental funding will provide RWHAP Parts A and B recipients with additional technical assistance (TA) specifically focused on resource allocation planning and implementation. These additional TA activities will build upon data elements identified in the Integrated Plan and PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 Date approval expires 0910–0256 0910–0330 0910–0409 5/31/2021 5/31/2021 5/31/2021 0910–0563 0910–0569 0910–0627 5/31/2021 5/31/2021 5/31/2021 0910–0633 5/31/2021 0910–0701 0910–0704 0910–0741 5/31/2021 5/31/2021 5/31/2021 0910–0782 5/31/2021 0910–0787 0910–0792 0910–0852 5/31/2021 5/31/2021 5/31/2021 provide jurisdictions with strategies, tools, and resources to effectively allocate annual available resources to prioritize HIV unmet needs. The TA activities will be directed at addressing more efficient and proactive methods in the Priority Setting and Resource Allocation (PSRA) process to increase the ability of health care providers and systems to ensure people living with HIV are linked to care, remain engaged in care, and achieve HIV viral suppression. Dated: June 12, 2018. George Sigounas, Administrator. [FR Doc. 2018–13121 Filed 6–18–18; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which E:\FR\FM\19JNN1.SGM 19JNN1

Agencies

[Federal Register Volume 83, Number 118 (Tuesday, June 19, 2018)]
[Notices]
[Page 28431]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-13121]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Ryan White HIV/AIDS Program Parts A and B Integrated HIV Planning 
Implementation Cooperative Agreement to John Snow, Inc. (JSI), 
U69HA30144

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services.

ACTION: Notice of non-competitive FY 2018 supplemental award.

-----------------------------------------------------------------------

SUMMARY: This noncompetitive supplement award to JSI will support and 
strengthen current Ryan White HIV/AIDS Program (RWHAP) Part A and Part 
B priority setting and resource allocation processes to ensure people 
living with HIV are linked to care, remain engaged in care, and achieve 
viral suppression.

FOR FURTHER INFORMATION CONTACT: Dr. Rene Sterling, Acting Director, 
Division of State HIV/AIDS Programs, HIV/AIDS Bureau, HRSA; 5600 
Fishers Lane, Room 09W50, Rockville, MD 20857; Phone: (301) 443-9017, 
Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Intended Recipient of the Award: JSI (U69HA30144).
    Amount of Non-Competitive Award: $300,000 in FY 2018.
    Period of Funding: July 1, 2018, through June 30, 2019.
    CFDA Number: No. 93.145.
    Authority: Sections 2606 and 2654(b) of the Public Health Service 
Act, as amended by the Ryan White HIV/AIDS Treatment Extension Act of 
2009 (Pub. L. 111-87).
    Justification: In 2016, JSI was awarded a 3-year cooperative 
agreement under HRSA-16-082 RWHAP Integrated HIV Planning 
Implementation (CFDA 93.145), authorized by Sections 2606 and 2654(b) 
of the Public Health Service Act, as amended by the Ryan White HIV/AIDS 
Treatment Extension Act of 2009 (Pub. L. 111-87). The cooperative 
agreement was established to provide technical assistance to RWHAP 
Parts A and B recipients and their planning bodies regarding: (1) The 
integration of HIV planning across prevention, care, and treatment 
service delivery systems; and (2) the development, implementation, 
monitoring, and evaluation of Integrated HIV Prevention and Care Plans. 
RWHAP Parts A and B recipients and planning bodies use Integrated Plans 
to better inform and coordinate HIV prevention and care program 
planning, resource allocation, and continuous quality improvement 
efforts to meet the HIV service delivery needs within their 
jurisdictions.
    The proposed supplemental funding will provide RWHAP Parts A and B 
recipients with additional technical assistance (TA) specifically 
focused on resource allocation planning and implementation. These 
additional TA activities will build upon data elements identified in 
the Integrated Plan and provide jurisdictions with strategies, tools, 
and resources to effectively allocate annual available resources to 
prioritize HIV unmet needs. The TA activities will be directed at 
addressing more efficient and proactive methods in the Priority Setting 
and Resource Allocation (PSRA) process to increase the ability of 
health care providers and systems to ensure people living with HIV are 
linked to care, remain engaged in care, and achieve HIV viral 
suppression.

    Dated: June 12, 2018.
George Sigounas,
Administrator.
[FR Doc. 2018-13121 Filed 6-18-18; 8:45 am]
 BILLING CODE 4165-15-P